Press release
Endometriosis Disease Pipeline Drugs Assessment: Clinical Trails Analysis, Player Profiles, Collaborations, Key Targets, Geographic Focus, and Data Publications, 2018
Endometriosis Disease Pipeline Drugs
Endometriosis is a condition in which the inner ling of uterus develops outside of uterus. Endometriosis is often painful and most commonly involves fallopian tubes, ovaries,and tissue that lining the pelvis. But, rarely endometriosis spreadsbeyond the pelvic organs. Exact cause of endometriosis is not known. Possible causes may be retrograde menstruation, embryonic cell transformation, surgical scar implantation, transformation of peritoneal cells or may be immune system disorders.
Endometriosis generally diagnosed by pelvic exam, ultrasound or through laparoscopy. Endometriosis treated with medications or surgery. Generally medications are preferred over surgical procedure. Medications include NSAIDs to manage pain, and hormones.
A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/endometriosis-disease-pipeline-drugs-assessment/#ulp-4H8Z4LpNMLEuOnnx
Segmentation:
By route of administration, endometriosis pipeline drugs are segmented into
• Oral
• Parenteral
• Others
By Trial Phase, Endometriosis pipeline drugs are segmented as:
• Preclinical Trials
• Phase 1
• Phase 2
• Phase 3
By Company, Endometriosis pipeline drugs are segmented as:
• AbbVie Inc. (U.S.)
• ObsEva (Switzerland)
• Bayer AG (Germany)
• Repros Therapeutics Inc. (U.S.)
To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/endometriosis-disease-pipeline-drugs-assessment/#ulp-c654SbFYO64MsOhu
Space Analysis:
Many of the companies are focused on the treatment of pain management associated with the endometriosis. Furthermore, companies are adopting collaborations to develop the new drugs for the treatment of endometriosis. For instance, In October 2012, Evotec AG and Bayer AG entered into five-yearmulti-target collaboration to develop clinical candidates for treatment of endometriosis. In July 2017, companies have announced extension of its alliance toend of 2018 along with milestone payment by Bayer AG. In addition, composition patent of Lupron is going to expire in 2019 and it may open gateway for the generic entry.
• In November 2017, Abbive Inc. announced detailed results from two replicate phase 3 clinical studies evaluating the long-term efficiency and safety of elagolix, orally administered gonadotrophin-releasinghormone being evaluated for endometriosis associated with pain. The results found to be positive and the results, and other additional abstracts, were presented at the American Society for Reproductive Medicine Scientific Congress & Expo (ASRM) in San Antonio,
• In November 2017, ObsEva SA announced completion of patient recruitment of Phase 2b EDELWEISS clinical trial of itaGnRHreceptor antagonist, OBE2109 for the treatment of pain associated with endometriosis.
Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/endometriosis-disease-pipeline-drugs-assessment/#ulp-14mlyhjMGhVjZqa3
Report Description:
Endometriosis Disease Pipeline Drugs Assessment report studies the various therapeutics under clinical development for Endometriosis treatment along with targets for various drug candidate. The report provides plethora of information pertaining to trail phases, companies involved in the Endometriosis disease pipeline drugs development. This report studies the dynamics of the Endometriosis Disease Pipeline Drugs i.e. drivers, challenges, and opportunities which are significantly impacting the product development. The report provides various information pertaining the clinical trials such as designation, grants, patents, and technology among others. Moreover, the report on Endometriosis disease pipeline drugs assessment comprehensively presents the geographic location, trial status information along with key players involved in the therapeutics development.
Key Features of the Report:
• Provides the information related to universities and research institutes working in the therapeutics development
• Report comprehensively covers the all active and discontinued studies
• Studies the entire pipeline with special emphasis on companies actively involved in the therapeutics development
• Presents the prominent targets for drug development in each stage of clinical trial
• Provides the in-depth analysis of each drug candidates in the clinical trial phases
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/endometriosis-disease-pipeline-drugs-assessment/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Endometriosis Disease Pipeline Drugs Assessment: Clinical Trails Analysis, Player Profiles, Collaborations, Key Targets, Geographic Focus, and Data Publications, 2018 here
News-ID: 1049093 • Views: …
More Releases from Precision Business Insights
Biochar Market Growth Is Attributed To The Increased Production Of Biochar Throu …
According to Precision Business Insights (PBI), the latest report biochar market was valued at USD 243.8 million in 2022, growing at a 12.6% CAGR during the forecast period 2023 to 2029. The rising demand for organic and eco-friendly products drives the biochar market. Utilizing biochar corresponds with organic farming methods, improving market prospects. Furthermore, biochar is a potential material for water treatment and remediation because of its capacity to absorb…
Vapor Recovery Units Market Growth Is Attributed To The Increased Adoption Of Me …
According to Precision Business Insights (PBI), latest report vapor recovery units market was valued at USD 923.7 million in 2022 and is poised to grow at a CAGR of 4.2% during the forecast period 2023 to 2029. The adoption of stringent environmental regulations by governments and international bodies to reduce air pollution and greenhouse gas emissions in various countries drives the demand for the vapor recovery unit's market. Furthermore, the…
Pyrite Market Growth Is Attributed To The Increased Demand In Jewelry Industry
According to Precision Business Insights (PBI), latest report pyrite market is growing at 4.9% CAGR during the forecast period 2023 to 2029. The increased application of pyrite in the manufacturing of sulfuric acid drives the pyrite market. The increase of prices of gold has led to increased demand for imitation jewelry which is anticipated to propel the pyrite market growth. Furthermore, the demand for sulphuric acid in a variety of…
Industrial Boilers Market Growth Is Attributed To The Increased Use In Power Gen …
According to Precision Business Insights (PBI), the latest report industrial boilers market size was valued at USD 15,261.8 million in 2022 and is poised to grow at a 3.1% CAGR during the forecast period 2023 to 2029. The adoption of stringent environmental regulations to maintain emission standards and carbon reduction in several countries drives the industrial boilers market. Furthermore, the advancement in boiler technology, such as better combustion systems, greater…
More Releases for Endometriosis
Endometriosis Market Trends, Size, Forecast - 2018-2023
Endometriosis is a painful disorder in which the layer of tissue that normally surfaces inside the uterus, starts growing outside the uterus. This mainly occurs on the fallopian tubes, ovaries, and tissue around the uterus; however, in exceptional cases it may occur in other parts of the body. The endometriosis leads to various physical symptoms such as severe menstrual cramps, nausea and vomiting, fatigue, diarrhea, constipation, long-term pelvic pain, and…
Global Endometriosis Market Research and Forecast 2018-2023
Global endometriosis market size, share, market trends, research and analysis report by diagnosis (ultrasound, pelvic exam, laparoscopy, MRI, hysteroscopy, son hysterography) by treatment (hormonal therapy, pain management) forecast 2018-2023
According to the OMR analysis, the global endometriosis market is growing at a significant rate during 2018-2023. The global endometriosis market has been growing significantly due availability of enhanced medications for the disease. The global endometriosis market is segmented on the basis…
Endometriosis Therapies Market: Competitive Dynamics & Global Outlook 2023
New report published by Global Info Research which offers insights on the global Endometriosis Therapies market.
Therapies used to treat endometriosis include: Hormonal contraceptives. Birth control pills, patches and vaginal rings help control the hormones responsible for the buildup of endometrialtissue each month
Click to view the full report TOC, figure and tables：
https://www.globalinforesearch.com/global-endometriosis-therapies-market_p87118.html
Global Endometriosis Therapies Market: Forecast by Type / Application / Region
The worldwide market for…
Endometriosis-Pipeline Review H2 2018
Endometriosis-Pipeline Review, H2 2018
Summary
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Endometriosis-Pipeline Review, H2 2018, provides an overview of the Endometriosis (Women's Health) pipeline landscape.
Endometriosis is an often painful disorder in which tissue that normally lines the inside of uterus (endometrium) grows outside uterus (endometrial implant). Symptoms include pelvic pain, menstrual cramps, inflammation, infertility and abnormal bleeding. Risk factors age, uterine abnormalities, history of pelvic infection and family history. Treatment…
Global Endometriosis Market Research and Forecast 2018-2023
Endometriosis is a painful disorder in which the layer of tissue that normally surfaces inside the uterus, starts growing outside the uterus. This mainly occurs on the fallopian tubes, ovaries, and tissue around the uterus; however, in exceptional cases it may occur in other parts of the body. The endometriosis leads to various physical symptoms such as severe menstrual cramps, nausea and vomiting, fatigue, diarrhea, constipation, long-term pelvic pain, and…
Global Endometriosis Treatment Market has Great Future Ahead
Qyresearchreports include new market research report Global Endometriosis Treatment Market Size,Status and Forecast 2025 to its huge collection of research reports.
The comprehensive study on the global Endometriosis Treatment market recently added to our vast repository of market reports is an expansive resource for leading and new companies on the hunt for intelligent information to fabricate production and marketing strategies. The report uncovers insights on the market for Endometriosis Treatment through…
